FolioObs › BROWN & BROWN INC (BRO) › Earnings calls

BROWN & BROWN INC earnings calls

BRO · every analyst question and management's answer

Oct 27, 2026 earnings call — Accession integration and market headwinds

Company reported $1.7 billion revenue, adjusted EBITDAC margin 34.6%, and EPS $1.07 for Q3.

Revenue $1.7B (est $1.8B) · EPS $1.07 (est $1.09)

Key quotes

"we are increasing our full-year 2026 expected benefit to approximately $50 million."

— Andy · Accession integration and synergies

"Specialty distribution had some incremental headwinds and came in below our expectations, which we will talk about in a few minutes."

— Powell Brown (CEO) · Specialty distribution headwinds

"COMPASS is a connected, intelligent ecosystem that integrates AI-powered capabilities with our proprietary data analytics and specialized knowledge within our retail segment to support important risk management decisions and recommendations."

— Powell Brown (CEO) · AI and COMPASS rollout

Analyst Q&A 15

specialty growth outlook

Q (Michael Phillips · Oppenheimer): Analyst asked why specialty is expected to rebound 1%-3% and whether listed headwinds are persistent. He also asked how specialty will recover given those headwinds.

A: Management said Accession-acquired specialty businesses (reinsurance, MGU, affinity, captive management) and timing of the lender-placed program will drive growth next year. They expect those gains to offset cat and wholesale headwinds and produce low single-digit organic growth.

"We feel comfortable with that growth from those businesses, that'll help offset the headwinds on the cat programs as well as wholesale and get us into that low single digits for organic growth." — Andy

hiring and producer retention

Q (Andrew Kligerman · TD Cowen): Analyst asked for net hiring color and producer count changes this year and next. He also asked if Accession caused any temporary slowdown in acquired-business organic growth.

A: Management said they are hiring more producers and will need talent to reach $8 billion revenue. They said producer retention at legacy Accession was similar to Brown & Brown and they are pleased with retention after the acquisition.

"Our producer retention inside of our organization, and remember, we don't talk about Accession anymore post 8/1, but the retention of our producers in that business prior to the one-year anniversary and Brown & Brown were very similar." — Powell Brown (CEO)

integration extra expense

Q (Gregory Peters · Raymond James): Analyst asked about the $90 million unusual expense outside the $250M-$300M synergy number and for an integration progress update. He asked if heavy lifting is done.

A: Management said legacy Accession had prior acquisition agreements that now must be expensed under GAAP, which is the $90 million shown in integration costs. They said some systems work, office consolidations, and specialty distribution combinations still remain.

"In that case, GAAP is going to require that we actually expense those because they are associated with performance in the future." — Andy

margins and cash flow outlook

Q (Mark Hughes · Truist): Analyst asked early thoughts on Q4 and 2027 EBITDAC margins and about cash flow trends next year. He also asked about quake pressure causes.

A: Management said they have no 2027 margin guidance yet but expect Q4 margins to be down versus last year given revenue and contingent commentary. They expect cash conversion to trend toward their normal 24%-26% of revenues and see both pricing pressure and admitted carriers taking quake risk.

"As it relates to the fourth quarter, if you take into consideration our commentary on revenue guidance as well as contingents, we would expect the margins will be down in the fourth quarter compared to last year." — Andy

walking away from programs

Q (Tracy Benguigui · Wolfe): Analyst asked whether walking away from programs is driven by fronting carriers pulling back or by Brown & Brown's own profitability hurdles. She asked if discipline is carrier-driven or internal.

A: Management clarified they may walk away from specific accounts inside programs, not whole programs, and that they must deliver profitable premium to carrier partners. If an account doesn't fit carrier parameters or their profitability standards, they will not accept it.

"At the end of the day, we believe that we must deliver profitable growth or profitable premium to our carrier partners." — Powell Brown (CEO)

margin ceiling and tech

Q (Pablo Singzon · JPMorgan (questioner listed as Pablo earlier but this was Pablo)): Analyst asked if margins have a structural ceiling, whether tech/AI can lift margins, and if margin expansion needs specialty to outgrow retail.

A: Management said margin expansion does not require specialty to outgrow retail and that organic, profitable growth is the goal. They noted margins could be higher if they stopped investing, but they will continue balanced investments to support long-term growth.

"What we want to do is grow the business more organically with good margins." — Powell Brown (CEO)

litigation timeline and Accession revenue

Q (Rob Cox · Goldman Sachs): Analyst asked whether litigation impacts will linger into 2027 and about Accession revenues versus expectations and retention concerns.

A: Management said litigation will likely stretch for a while with uncertain timing and that some revenue will carry into 2027 but probably not a significant amount. They said the acquisition revenue remains around the $1.7 billion range, they disposed of some non-strategic businesses, and producer retention at Accession was strong.

"I think that that is going to stretch for a while." — Powell Brown (CEO)

retail and programs timing

Q (Elyse Greenspan · Wells Fargo): Analyst asked what is driving retail's 2%-4% outlook for Q4 and 2027 and whether lender-placed timing items will reverse in 2027. She asked if Accession is a tailwind for programs.

A: Management said retail improvement reflects execution of a go-to-market plan rolled out in Q1 that started showing opportunities in Q3 and into Q4. They confirmed the specialty distribution 2027 guidance includes timing from this year coming online and said they no longer break out legacy Accession separately.

"On the guidance for specialty distribution for 2027, yes, that would include the timing from this year being recognized in 2027." — Andy

Europe wholesale investment

Q (Andrew Andersen · Jefferies): Analyst asked what Brown is investing in for European wholesale, targeted growth opportunities, and when investments will help organic growth and margins. He also asked about tech spend trajectory.

A: Management said 2026 investments have bolstered North American and international wholesale capabilities, including the London brokerage and program businesses, and they expect benefits to continue into next year. They said tech and related spending details will be provided on the January call.

"We've been making those investments throughout this year, the calendar year of 2026, and that would be embellishing North American wholesale capabilities and international wholesale capabilities." — Powell Brown (CEO)

client retention and synergies

Q (Alex Scott · Barclays): Analyst asked if retail client retention is weakening industrywide and whether Brown is a net winner of churn. He also asked if increased synergy guidance is expense or revenue synergies.

A: Management said some churn rises when prices change and Brown & Brown has seen modest churn but is writing a lot of new business and views opportunities positively. They said most of the original $150 million and most of the incremental $25 million in synergy upside are expected to be expense synergies.

"Most of that incremental 25 is also anticipated to come from expense synergies." — Andy

share buybacks and cash use

Q (Yaron Kinar · Mizuho): Analyst asked why buybacks were steady despite stronger free cash flow and whether management would accelerate repurchases instead of holding cash for debt repayment.

A: Management said they prefer deploying cash where it best fits, will buy stock when price is appealing, and are not considering a leveraged buyback. They noted upcoming debt repayment in December and that share repurchases remain a top capital use after buying back substantial shares this year.

"We will continue to try to deploy the capital in the best ways that we think make sense, and share repurchases right now are right near the top." — Powell Brown (CEO)

unit volume vs pricing

Q (Josh Shanker · BofA): Analyst asked how to think about unit volume versus pricing in organic guidance and whether Brown is busy despite modest percentage growth. He asked how more admitted product affects competition.

A: Management said many factors affect revenue beyond unit counts—rate, exposures, limits, deductibles—and that activity varies by region. They emphasized they control quality of products and advice even if they can't control macroeconomics or pricing, and that they are seeing policy growth in several programs.

"We cannot control the economy, we cannot control pricing, but we can control the quality of the products and the thought process and the advice that we give to our customers and prospects." — Powell Brown (CEO)

property pricing outlook

Q (Meyer Shields · Keefe, Bruyette & Woods): Analyst asked for the property pricing assumptions behind specialty distribution's 2027 outlook and whether CAT property rate declines are expected.

A: Management said they are still finalizing budgets but see industry CAT property rates down roughly 10% to 20%, and they believe it's on the high end of that range. They will finalize projections this quarter and provide more detail on the next call.

"I would tell you that there is a feeling out there that property rates CAT property rates will be somewhere between 10% and 20% down in the industry." — Powell Brown (CEO)

employee benefits pressures

Q (Bob Huang · Morgan Stanley): Analyst asked what is pressuring employee benefits pricing and whether negative trends will continue into 2027, mentioning workers' comp and disability.

A: Management said key EB pressures are medical trend, high-cost claimants, and specialty pharmacy, with medical trend seen around 7%-9% depending on the source. They said specialty pharmacy usage and high-cost claimants will keep cost pressure, and plan design conversations are ongoing with clients to manage cost.

"Medical trend, 7%-9%, depending on who you are talking to, typically." — Powell Brown (CEO)

retail go-to-market plan

Q (Michael Zaremski · BMO): Analyst asked if retail's 2%-4% organic is business as usual or if Steve Hearn's plan materially changes outcomes and what the plan fixes.

A: Management said Steve Hearn's plan improved how they leverage existing capabilities and combine them with Accession's added teammates and capabilities. They said much integration work is complete, execution is improving, leadership is strong, and they are positive about the future while acknowledging some divisions must still improve.

"I am the most pleased with the leadership team and the way we are delivering for our customers than I ever have been, number one." — Powell Brown (CEO)

AI-generated notes on the earnings call transcript. Quotes are taken from the transcript. This is not a FolioObs investment view.

BROWN & BROWN INC (BRO) · Earnings calendar

FolioObs Features | 주요 기능

  • Dashboard — SEC 13F Portfolio Tracker, FolioObs 50 | 대시보드
  • AI Insights — Portfolio Analysis & Signals | AI 인사이트
  • Insider Trading — SEC Form 4 Tracker | 내부자 거래
  • Cathie Wood Today's Trades + AI Insights | 캐시 우드 오늘의 매매
  • ARK Invest Report — Daily Trades | ARK 리포트
  • Investment News — Data-Driven Updates | 뉴스
  • Weekly Report — Market Movers | 주간 리포트
  • How to Read a 13F — 5-Minute Guide | 13F 읽는 법
  • The FolioObs 50 — All Tracked Investors | FolioObs 50 전체 보기
  • Wall Street Consensus — Shared Holdings | 월가 컨센서스
  • US Politician Trades — STOCK Act | 정치인 매매 추적
  • Earnings Calendar | 실적 발표 캘린더

FolioObs 50 | 추적 중인 월가 투자자 50인

  • Warren Buffett — Berkshire Hathaway | 워렌 버핏
  • Cathie Wood — ARK Invest | 캐시 우드
  • Stanley Druckenmiller — Duquesne Family Office | 스탠리 드러켄밀러
  • Ray Dalio — Bridgewater Associates | 레이 달리오
  • George Soros — Soros Fund Management | 조지 소로스
  • Bill Ackman — Pershing Square Capital | 빌 애크먼
  • David Tepper — Appaloosa Management | 데이비드 테퍼
  • Chase Coleman — Tiger Global Management | 체이스 콜먼
  • Dan Loeb — Third Point | 댄 로엡
  • Seth Klarman — Baupost Group | 세스 클라만
  • National Pension Service (NPS) — Korea National Pension Service | 국민연금
  • David Einhorn — Greenlight Capital | 데이비드 아인혼
  • John Paulson — Paulson & Co | 존 폴슨
  • Howard Marks — Oaktree Capital Management | 하워드 막스
  • Leon Cooperman — Omega Family Office | 레온 쿠퍼먼
  • Ken Griffin — Citadel | 켄 그리핀
  • Steve Cohen — Point72 Asset Management | 스티브 코헨
  • Li Lu — Himalaya Capital | 리 루
  • Mohnish Pabrai — Pabrai Investment Funds | 모니시 파브라이
  • Bruce Berkowitz — Fairholme Capital Management | 브루스 버코비츠
  • Nelson Peltz — Trian Fund Management | 넬슨 펠츠
  • Carl Icahn — Icahn Capital | 칼 아이칸
  • Paul Singer — Elliott Management | 폴 싱어
  • Philippe Laffont — Coatue Management | 필립 라퐁
  • Andreas Halvorsen — Viking Global | 안드레아스 할보르센
  • Daniel Sundheim — D1 Capital | 다니엘 선드하임
  • Masayoshi Son — SoftBank Group | 손정의
  • Terry Smith — Fundsmith | 테리 스미스
  • Joel Greenblatt — Gotham Asset Management | 조엘 그린블랫
  • Bill Miller — Miller Value Partners | 빌 밀러
  • Brad Gerstner — Altimeter Capital | 브래드 거스트너
  • Rajiv Jain — GQG Partners | 라지브 자인
  • Duan Yongping — H&H International | 돤융핑
  • Chris Hohn — TCI Fund Management | 크리스 혼
  • Stephen Mandel — Lone Pine Capital | 스티븐 만델
  • Prem Watsa — Fairfax Financial | 프렘 왓사
  • Sequoia Fund — Ruane Cunniff & Goldfarb | 세쿼이아 펀드
  • Guy Spier — Aquamarine Capital | 가이 스파이어
  • Lee Ainslie — Maverick Capital | 리 아인슬리
  • David Abrams — Abrams Capital | 데이비드 아브람스
  • Pat Dorsey — Dorsey Asset Management | 팻 도시
  • Dev Kantesaria — Valley Forge Capital | 데브 칸테사리아
  • Francois Rochon — Giverny Capital | 프랑수아 로숑
  • Thomas Russo — Gardner Russo & Quinn | 토마스 루소
  • Tweedy Browne — Tweedy Browne | 트위디 브라운
  • Temasek — Temasek Holdings | 테마섹
  • Saudi PIF — Public Investment Fund | 사우디 국부펀드
  • Baillie Gifford — Baillie Gifford | 베일리 기포드
  • Ron Baron — Baron Capital | 론 배런
  • Thomas Gayner — Markel Group | 토마스 게이너